Publications
5674 Results
- Journal / Conference
- ASCO 14:235(#613)
- Year
- 1995
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8894 (INT-0105) (EST-2889)
The prognostic significance of prostate specific antigen (PSA) in stage D2 prostate cancer (PC) interim evaluation of Intergroup study 0105
- Journal / Conference
- ASCO 14:146(#281)
- Year
- 1995
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9401 (NCCTG-90-46-52)
Phase II study of taxol in patients (pts) with recurrent malignant glioma: North American Brain Tumor Consortium
- Journal / Conference
- Proc of the 48th Annual Cancer Symposium of the Society of Surgical Oncology :6
- Year
- 1995
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-8393 (INT-0013)
Local recurrence in malignant melanoma: Long-term results of the surgical trial.
- Journal / Conference
- Investigational New Drugs 13:167-170
- Year
- 1995
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8719
Phase II evaluation of didemnin B in hormonally refractory metastatic prostate cancer. A Southwest Oncology Group study.
- Journal / Conference
- Investigational New Drugs 13:83-87
- Year
- 1995
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-9116
A phase II trial of piroxantrone in disseminated malignant melanoma: A Southwest Oncology Group study.
- Journal / Conference
- Journal of Clinical Oncology 13(12):2924-2930
- Year
- 1995
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8812
Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: A Southwest Oncology Group study.
- Journal / Conference
- Journal of the American Statistical Association 90(429):95-105
- Year
- 1995
Semiparametric regression functionals.
- Journal / Conference
- Urologic Oncology 1:119-126
- Year
- 1995
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8795 (INT-0094) (EST-1888)
Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder. A Southwest Oncology Group study.
- Journal / Conference
- Journal of Clinical Oncology 13(4):1046
- Year
- 1995
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-8624
In reply
- Journal / Conference
- Investigational New Drugs 13:143-147
- Year
- 1995
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-8913